Basit öğe kaydını göster

dc.contributor.authorÇelik, Oğuz Cem
dc.contributor.authorKadioglu, P.
dc.date.accessioned2021-03-05T10:32:16Z
dc.date.available2021-03-05T10:32:16Z
dc.date.issued2010
dc.identifier.citationÇelik O. C. , Kadioglu P., "Medical therapy of acromegaly in Turkey", JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, cilt.33, ss.592-598, 2010
dc.identifier.issn0391-4097
dc.identifier.otherav_a39351d8-3e08-48c7-845b-f3b0cf53034c
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/109493
dc.identifier.urihttps://doi.org/10.1007/bf03346654
dc.description.abstractAcromegaly is associated with multiple co-morbidities and risk of premature mortality. Mortality rate of acromegalic patients is similar to that of the general population when normal GH levels are achieved. Surgery is the mainstay of acromegaly but when surgery fails to achieve disease control, or when surgery is impossible or contraindicated, patients are offered medical therapy and/or radiotherapy. Current medical therapy modalities were revised in this short review. (J. Endocrinol. Invest. 33: 592-598, 2010) (C) 2010, Editrice Kurtis
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleMedical therapy of acromegaly in Turkey
dc.typeMakale
dc.relation.journalJOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
dc.contributor.departmentİstanbul Teknik Üniversitesi , Mimarlık , Mimarlık
dc.identifier.volume33
dc.identifier.issue8
dc.identifier.startpage592
dc.identifier.endpage598
dc.contributor.firstauthorID50075


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster